APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cabazitaxel

Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.

Selected research

Industry Growth & Trends

Global Cabazitaxel Industry Growth and Trends Forecast to 2032

19 December 202577 pages

Choose your research edition.

Industry ResearchCabazitaxel Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Cabazitaxel Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Cabazitaxel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cabazitaxel Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cabazitaxel Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.

USA is the largest Cabazitaxel market with about 95% market share. Europe is follower, accounting for about 3% market share.The key manufacturers are Sanofi, Tapi Teva, Fuan Pharmaceutical Group, Fujian Yewpark Biological etc. Top 3 companies occupied about 99% market share.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Cabazitaxel market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cabazitaxel market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cabazitaxel market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cabazitaxel.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cabazitaxel market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cabazitaxel Market by Company

Sanofi

Tapi Teva

Fuan Pharmaceutical Group

Fujian Yewpark Biological

Cabazitaxel Segment by Type

Purity above 99%

Other Purity

Cabazitaxel Segment by Application

Age Below 65

Age Above 65

Cabazitaxel Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cabazitaxel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cabazitaxel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cabazitaxel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cabazitaxel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cabazitaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity above 99% Table 2. Major Company of Other Purity Table 3. Global Cabazitaxel Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cabazitaxel Sales by Type (2021-2026) & (Kg) Table 5. Global Cabazitaxel Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cabazitaxel Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cabazitaxel Sales Market Share in Value by Type (2021-2026) Table 8. Global Cabazitaxel Price by Type (2021-2026) & (USD/g) Table 9. Global Cabazitaxel Sales by Type (2027-2032) & (Kg) Table 10. Global Cabazitaxel Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cabazitaxel Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cabazitaxel Sales Market Share in Value by Type (2027-2032) Table 13. Global Cabazitaxel Price by Type (2027-2032) & (USD/g) Table 14. North America Cabazitaxel Sales by Type (2021-2026) & (Kg) Table 15. North America Cabazitaxel Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cabazitaxel Sales by Type (2021-2026) & (Kg) Table 17. Europe Cabazitaxel Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cabazitaxel Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Cabazitaxel Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cabazitaxel Sales by Type (2021-2026) & (Kg) Table 21. Latin America Cabazitaxel Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cabazitaxel Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Cabazitaxel Sales by Type (2021-2026) & (US$ Million) Table 24. Cabazitaxel Industry Trends Table 25. Cabazitaxel Industry Drivers Table 26. Cabazitaxel Industry Opportunities and Challenges Table 27. Cabazitaxel Industry Restraints Table 28. Global Cabazitaxel Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cabazitaxel Revenue Market Share by Company (2021-2026) Table 30. Global Cabazitaxel Sales by Company (2021-2026) & (Kg) Table 31. Global Cabazitaxel Sales Share by Company (2021-2026) Table 32. Global Cabazitaxel Market Price by Company (2021-2026) & (USD/g) Table 33. Global Cabazitaxel Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cabazitaxel Major Company Production Sites and Headquarters Table 35. Global Cabazitaxel Company, Product Type & Application Table 36. Global Cabazitaxel Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cabazitaxel by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cabazitaxel Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cabazitaxel Sales by Region (2021-2026) & (Kg) Table 41. Global Cabazitaxel Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cabazitaxel Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cabazitaxel Sales Market Share in Value by Region (2021-2026) Table 44. Global Cabazitaxel Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 45. Global Cabazitaxel Sales by Region (2027-2032) & (Kg) Table 46. Global Cabazitaxel Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cabazitaxel Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cabazitaxel Sales Market Share in Value by Region (2027-2032) Table 49. Global Cabazitaxel Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2027-2032) Table 50. Global Cabazitaxel Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cabazitaxel Sales by Application (2021-2026) & (Kg) Table 52. Global Cabazitaxel Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cabazitaxel Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cabazitaxel Sales Market Share in Value by Application (2021-2026) Table 55. Global Cabazitaxel Price by Application (2021-2026) & (USD/g) Table 56. Global Cabazitaxel Sales by Application (2027-2032) & (Kg) Table 57. Global Cabazitaxel Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cabazitaxel Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cabazitaxel Sales Market Share in Value by Application (2027-2032) Table 60. Global Cabazitaxel Price by Application (2027-2032) & (USD/g) Table 61. North America Cabazitaxel Sales by Application (2021-2026) & (Kg) Table 62. North America Cabazitaxel Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cabazitaxel Sales by Application (2021-2026) & (Kg) Table 64. Europe Cabazitaxel Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cabazitaxel Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Cabazitaxel Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cabazitaxel Sales by Application (2021-2026) & (Kg) Table 68. Latin America Cabazitaxel Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cabazitaxel Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Cabazitaxel Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Cabazitaxel Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 74. Sanofi Cabazitaxel Product Portfolio Table 75. Sanofi Recent Development Table 76. Tapi Teva Company Information Table 77. Tapi Teva Business Overview Table 78. Tapi Teva Cabazitaxel Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 79. Tapi Teva Cabazitaxel Product Portfolio Table 80. Tapi Teva Recent Development Table 81. Fuan Pharmaceutical Group Company Information Table 82. Fuan Pharmaceutical Group Business Overview Table 83. Fuan Pharmaceutical Group Cabazitaxel Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 84. Fuan Pharmaceutical Group Cabazitaxel Product Portfolio Table 85. Fuan Pharmaceutical Group Recent Development Table 86. Fujian Yewpark Biological Company Information Table 87. Fujian Yewpark Biological Business Overview Table 88. Fujian Yewpark Biological Cabazitaxel Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 89. Fujian Yewpark Biological Cabazitaxel Product Portfolio Table 90. Fujian Yewpark Biological Recent Development Table 91. North America Cabazitaxel Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 92. North America Cabazitaxel Sales by Country (2021-2026) & (Kg) Table 93. North America Cabazitaxel Sales Market Share by Country (2021-2026) Table 94. North America Cabazitaxel Sales Forecast by Country (2027-2032) & (Kg) Table 95. North America Cabazitaxel Sales Market Share Forecast by Country (2027-2032) Table 96. North America Cabazitaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Cabazitaxel Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Cabazitaxel Market Share by Country (2021-2026) Table 99. North America Cabazitaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Cabazitaxel Market Share Forecast by Country (2027-2032) Table 101. Europe Cabazitaxel Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 102. Europe Cabazitaxel Sales by Country (2021-2026) & (Kg) Table 103. Europe Cabazitaxel Sales Market Share by Country (2021-2026) Table 104. Europe Cabazitaxel Sales Forecast by Country (2027-2032) & (Kg) Table 105. Europe Cabazitaxel Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Cabazitaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Cabazitaxel Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Cabazitaxel Market Share by Country (2021-2026) Table 109. Europe Cabazitaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Cabazitaxel Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Cabazitaxel Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Cabazitaxel Sales by Country (2021-2026) & (Kg) Table 113. Asia-Pacific Cabazitaxel Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Cabazitaxel Sales Forecast by Country (2027-2032) & (Kg) Table 115. Asia-Pacific Cabazitaxel Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Cabazitaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Cabazitaxel Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Cabazitaxel Market Share by Country (2021-2026) Table 119. Asia-Pacific Cabazitaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Cabazitaxel Market Share Forecast by Country (2027-2032) Table 121. Latin America Cabazitaxel Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 122. Latin America Cabazitaxel Sales by Country (2021-2026) & (Kg) Table 123. Latin America Cabazitaxel Sales Market Share by Country (2021-2026) Table 124. Latin America Cabazitaxel Sales Forecast by Country (2027-2032) & (Kg) Table 125. Latin America Cabazitaxel Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Cabazitaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Cabazitaxel Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Cabazitaxel Market Share by Country (2021-2026) Table 129. Latin America Cabazitaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Cabazitaxel Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Cabazitaxel Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Cabazitaxel Sales by Country (2021-2026) & (Kg) Table 133. Middle East and Africa Cabazitaxel Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Cabazitaxel Sales Forecast by Country (2027-2032) & (Kg) Table 135. Middle East and Africa Cabazitaxel Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Cabazitaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Cabazitaxel Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Cabazitaxel Market Share by Country (2021-2026) Table 139. Middle East and Africa Cabazitaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Cabazitaxel Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Cabazitaxel Distributors List Table 144. Cabazitaxel Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Cabazitaxel Image Figure 2. Global Cabazitaxel Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cabazitaxel Market Size (2021-2032) & (US$ Million) Figure 4. Global Cabazitaxel Sales (2021-2032) & (Kg) Figure 5. Purity above 99% Image Figure 6. Global Purity above 99% Sales YoY Growth (2021-2032) & (Kg) Figure 7. Other Purity Image Figure 8. Global Other Purity Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Cabazitaxel Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cabazitaxel Market Share by Type 2025 VS 2032 Figure 11. North America Cabazitaxel Sales Market Share in Volume by Type in 2025 Figure 12. North America Cabazitaxel Sales Market Share in Value by Type in 2025 Figure 13. Europe Cabazitaxel Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cabazitaxel Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cabazitaxel Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cabazitaxel Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cabazitaxel Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cabazitaxel Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cabazitaxel Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cabazitaxel Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cabazitaxel Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Age Below 65 Image Figure 24. Global Age Below 65 Sales YoY Growth (2021-2032) & (Kg) Figure 25. Age Above 65 Image Figure 26. Global Age Above 65 Sales YoY Growth (2021-2032) & (Kg) Figure 27. Global Cabazitaxel Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Cabazitaxel Market Share by Application 2025 VS 2032 Figure 29. North America Cabazitaxel Sales Market Share in Volume by Application in 2025 Figure 30. North America Cabazitaxel Sales Market Share in Value by Application in 2025 Figure 31. Europe Cabazitaxel Sales Market Share in Volume by Application in 2025 Figure 32. Europe Cabazitaxel Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Cabazitaxel Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Cabazitaxel Sales Market Share in Value by Application in 2025 Figure 35. Latin America Cabazitaxel Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Cabazitaxel Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Cabazitaxel Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Cabazitaxel Sales Market Share in Value by Application in 2025 Figure 39. North America Cabazitaxel Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 40. North America Cabazitaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Cabazitaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Cabazitaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Cabazitaxel Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. Europe Cabazitaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cabazitaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Cabazitaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Cabazitaxel Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Asia-Pacific Cabazitaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cabazitaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Cabazitaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Cabazitaxel Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Latin America Cabazitaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cabazitaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Cabazitaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Cabazitaxel Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Middle East and Africa Cabazitaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cabazitaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Cabazitaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Cabazitaxel Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Cabazitaxel Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Purity above 99%
  • Other Purity
Applications
  • Age Below 65
  • Age Above 65
Companies covered
  • Sanofi
  • Tapi Teva
  • Fuan Pharmaceutical Group
  • Fujian Yewpark Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cabazitaxel Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cabazitaxel Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cabazitaxel Market by Type
  6. 1.3.1 Purity above 99%
  7. 1.3.2 Other Purity
  8. 1.4 Global Cabazitaxel Market Size by Type
  9. 1.4.1 Global Cabazitaxel Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cabazitaxel Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cabazitaxel Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cabazitaxel Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cabazitaxel Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cabazitaxel Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cabazitaxel Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cabazitaxel Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cabazitaxel Industry Trends
  2. 2.2 Cabazitaxel Industry Drivers
  3. 2.3 Cabazitaxel Industry Opportunities and Challenges
  4. 2.4 Cabazitaxel Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cabazitaxel Revenue (2021-2026)
  2. 3.2 Global Top Players by Cabazitaxel Sales (2021-2026)
  3. 3.3 Global Top Players by Cabazitaxel Price (2021-2026)
  4. 3.4 Global Cabazitaxel Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cabazitaxel Major Company Production Sites & Headquarters
  6. 3.6 Global Cabazitaxel Company, Product Type & Application
  7. 3.7 Global Cabazitaxel Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cabazitaxel Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cabazitaxel Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cabazitaxel Tier 1, Tier 2, and Tier 3
4 Cabazitaxel Regional Status and Outlook
  1. 4.1 Global Cabazitaxel Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cabazitaxel Historic Market Size by Region
  3. 4.2.1 Global Cabazitaxel Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cabazitaxel Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cabazitaxel Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cabazitaxel Forecasted Market Size by Region
  7. 4.3.1 Global Cabazitaxel Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cabazitaxel Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cabazitaxel Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cabazitaxel by Application
  1. 5.1 Cabazitaxel Market by Application
  2. 5.1.1 Age Below 65
  3. 5.1.2 Age Above 65
  4. 5.2 Global Cabazitaxel Market Size by Application
  5. 5.2.1 Global Cabazitaxel Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Cabazitaxel Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Cabazitaxel Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Cabazitaxel Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Cabazitaxel Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Cabazitaxel Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Cabazitaxel Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Cabazitaxel Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Cabazitaxel Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Cabazitaxel Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Tapi Teva
  8. 6.2.1 Tapi Teva Company Information
  9. 6.2.2 Tapi Teva Business Overview
  10. 6.2.3 Tapi Teva Cabazitaxel Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tapi Teva Cabazitaxel Product Portfolio
  12. 6.2.5 Tapi Teva Recent Developments
  13. 6.3 Fuan Pharmaceutical Group
  14. 6.3.1 Fuan Pharmaceutical Group Company Information
  15. 6.3.2 Fuan Pharmaceutical Group Business Overview
  16. 6.3.3 Fuan Pharmaceutical Group Cabazitaxel Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fuan Pharmaceutical Group Cabazitaxel Product Portfolio
  18. 6.3.5 Fuan Pharmaceutical Group Recent Developments
  19. 6.4 Fujian Yewpark Biological
  20. 6.4.1 Fujian Yewpark Biological Company Information
  21. 6.4.2 Fujian Yewpark Biological Business Overview
  22. 6.4.3 Fujian Yewpark Biological Cabazitaxel Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fujian Yewpark Biological Cabazitaxel Product Portfolio
  24. 6.4.5 Fujian Yewpark Biological Recent Developments
7 North America by Country
  1. 7.1 North America Cabazitaxel Sales by Country
  2. 7.1.1 North America Cabazitaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cabazitaxel Sales by Country (2021-2026)
  4. 7.1.3 North America Cabazitaxel Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cabazitaxel Market Size by Country
  6. 7.2.1 North America Cabazitaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cabazitaxel Market Size by Country (2021-2026)
  8. 7.2.3 North America Cabazitaxel Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cabazitaxel Sales by Country
  2. 8.1.1 Europe Cabazitaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cabazitaxel Sales by Country (2021-2026)
  4. 8.1.3 Europe Cabazitaxel Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cabazitaxel Market Size by Country
  6. 8.2.1 Europe Cabazitaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cabazitaxel Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cabazitaxel Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cabazitaxel Sales by Country
  2. 9.1.1 Asia-Pacific Cabazitaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cabazitaxel Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cabazitaxel Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cabazitaxel Market Size by Country
  6. 9.2.1 Asia-Pacific Cabazitaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cabazitaxel Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cabazitaxel Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cabazitaxel Sales by Country
  2. 10.1.1 South America Cabazitaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cabazitaxel Sales by Country (2021-2026)
  4. 10.1.3 South America Cabazitaxel Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cabazitaxel Market Size by Country
  6. 10.2.1 South America Cabazitaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cabazitaxel Market Size by Country (2021-2026)
  8. 10.2.3 South America Cabazitaxel Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cabazitaxel Sales by Country
  2. 11.1.1 Middle East and Africa Cabazitaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cabazitaxel Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cabazitaxel Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cabazitaxel Market Size by Country
  6. 11.2.1 Middle East and Africa Cabazitaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cabazitaxel Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cabazitaxel Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cabazitaxel Value Chain Analysis
  2. 12.1.1 Cabazitaxel Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cabazitaxel Production Mode & Process
  7. 12.2 Cabazitaxel Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cabazitaxel Distributors
  10. 12.2.3 Cabazitaxel Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst